Robert Blum
President & Chief Executive Officer, Cytokinetics

Robert Blum is President, Chief Executive Officer and a member of the Board of Cytokinetics, a leading biopharmaceutical company he helped to launch in 1998 that is focused to the biology of muscle function.  Previously he held senior positions in Business Development and Marketing at COR Therapeutics and also performed roles of increasing responsibility in various pharmaceutical business functions at Marion Laboratories and Syntex Corporation.  Robert serves on the Board of BayBio and is on faculty at the Center for BioEntrepreneurship at UC San Francisco.  In addition, he serves on the Board of the American Committee of the Weizmann Institute of Science and established the Blum Family Venture Philanthropy Fund to propel basic science discoveries at the Institute with potential to benefit the Israeli life sciences economy. Robert also serves on the Board of the Jewish Community Federation of San Francisco and founded and chaired its Business Leadership Council.   Robert was recently named a Henry Crown Fellow of the Aspen Institute in recognition of his leadership in corporate and civic responsibilities.  Mr. Blum received B.A. degrees in Human Biology and Economics from Stanford University and an M.B.A. from Harvard Business School.

Back to Confirmed Speakers